Elevance Health, Inc.
ELV
$289.10
$8.673.09%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.68% | 12.80% | |||
| Total Other Revenue | 8.16% | -14.49% | |||
| Total Revenue | 1.81% | 7.59% | |||
| Cost of Revenue | 3.95% | 5.41% | |||
| Gross Profit | -3.75% | 13.71% | |||
| SG&A Expenses | 0.07% | -4.57% | |||
| Depreciation & Amortization | -5.16% | -13.89% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.04% | 2.91% | |||
| Operating Income | -16.17% | 218.24% | |||
| Income Before Tax | -18.06% | 361.55% | |||
| Income Tax Expenses | -10.60% | 217.62% | |||
| Earnings from Continuing Operations | -20.15% | 428.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | -120.00% | |||
| Net Income | -20.16% | 422.25% | |||
| EBIT | -16.17% | 218.24% | |||
| EBITDA | -14.26% | 153.72% | |||
| EPS Basic | -19.73% | 433.10% | |||
| Normalized Basic EPS | -17.63% | 335.64% | |||
| EPS Diluted | -19.67% | 431.32% | |||
| Normalized Diluted EPS | -17.56% | 334.11% | |||
| Average Basic Shares Outstanding | -0.53% | -2.03% | |||
| Average Diluted Shares Outstanding | -0.62% | -1.69% | |||
| Dividend Per Share | 0.00% | 4.91% | |||
| Payout Ratio | 0.25% | -0.80% | |||